Products/Services Used | Details | Operation |
---|---|---|
Catalog Antibody> | For the PD-1:PD-L1 blockade assay, the following mAbs were added at a final concentration of 5 μg/ml: anti-PD1 mouse IgG1 (Cat: A01829, Clone: PD1.D3; GenScript), mouse IgG1 isotype control (Cat: MAB002, Clone: #11711; R&D), anti-PD-L1 human IgG1 (N298A) (Cat: hpdl1-mab12; InvivoGen, equivalent to atezolizumab), and human IgG1 isotype control (N298A) (Cat: bgal-mab12; InvivoGen) | Get A Quote |
We previously reported two siblings with inherited PD-1 deficiency who died from autoimmune pneumonitis at 3 and 11 years of age after developing other autoimmune manifestations, including type 1 diabetes (T1D). We report here two siblings, aged 10 and 11 years, with neonatal-onset T1D (diagnosed at the ages of 1 day and 7 wk), who are homozygous for a splice-site variant of CD274 (encoding PD-L1). This variant results in the exclusive expression of an alternative, loss-of-function PD-L1 protein isoform in overexpression experiments and in the patients' primary leukocytes. Surprisingly, cytometric immunophenotyping and single-cell RNA sequencing analysis on blood leukocytes showed largely normal development and... More